1. Home
  2. OMH vs DRMA Comparison

OMH vs DRMA Comparison

Compare OMH & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • DRMA
  • Stock Information
  • Founded
  • OMH 2015
  • DRMA 2014
  • Country
  • OMH Singapore
  • DRMA United States
  • Employees
  • OMH N/A
  • DRMA N/A
  • Industry
  • OMH Real Estate
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMH Finance
  • DRMA Health Care
  • Exchange
  • OMH Nasdaq
  • DRMA Nasdaq
  • Market Cap
  • OMH N/A
  • DRMA 6.1M
  • IPO Year
  • OMH 2023
  • DRMA 2021
  • Fundamental
  • Price
  • OMH $2.23
  • DRMA $0.99
  • Analyst Decision
  • OMH Strong Buy
  • DRMA Strong Buy
  • Analyst Count
  • OMH 1
  • DRMA 1
  • Target Price
  • OMH $15.00
  • DRMA $6.00
  • AVG Volume (30 Days)
  • OMH 17.0K
  • DRMA 4.1M
  • Earning Date
  • OMH 01-01-0001
  • DRMA 05-14-2025
  • Dividend Yield
  • OMH N/A
  • DRMA N/A
  • EPS Growth
  • OMH N/A
  • DRMA N/A
  • EPS
  • OMH N/A
  • DRMA N/A
  • Revenue
  • OMH $5,390,607.00
  • DRMA N/A
  • Revenue This Year
  • OMH $111.47
  • DRMA N/A
  • Revenue Next Year
  • OMH $32.08
  • DRMA N/A
  • P/E Ratio
  • OMH N/A
  • DRMA N/A
  • Revenue Growth
  • OMH 25.77
  • DRMA N/A
  • 52 Week Low
  • OMH $0.25
  • DRMA $0.95
  • 52 Week High
  • OMH $2.70
  • DRMA $6.66
  • Technical
  • Relative Strength Index (RSI)
  • OMH 63.38
  • DRMA 35.86
  • Support Level
  • OMH $2.12
  • DRMA $1.16
  • Resistance Level
  • OMH $2.31
  • DRMA $2.37
  • Average True Range (ATR)
  • OMH 0.23
  • DRMA 0.17
  • MACD
  • OMH -0.07
  • DRMA -0.03
  • Stochastic Oscillator
  • OMH 25.34
  • DRMA 2.86

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: